ORPEA SA operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals. More Details
Moderate growth potential with poor track record.
Share Price & News
How has Orpea's share price performed over time and what events caused price changes?
Latest Share Price and Events
Stable Share Price: ORP is not significantly more volatile than the rest of French stocks over the past 3 months, typically moving +/- 5% a week.
Volatility Over Time: ORP's weekly volatility (5%) has been stable over the past year.
7 Day Return
1 Year Return
Return vs Industry: ORP exceeded the French Healthcare industry which returned -9.1% over the past year.
Return vs Market: ORP exceeded the French Market which returned -4.6% over the past year.
Long-Term Price Volatility Vs. Market
How volatile is Orpea's share price compared to the market and industry in the last 5 years?
Simply Wall St News
1 week ago | Simply Wall StHere's What To Make Of Orpea's (EPA:ORP) Returns On Capital
3 weeks ago | Simply Wall StAre Institutions Heavily Invested In Orpea SA's (EPA:ORP) Shares?
3 months ago | Simply Wall StIs Orpea (EPA:ORP) Likely To Turn Things Around?
Is Orpea undervalued compared to its fair value and its price relative to the market?
Price to Earnings (PE) ratio
Share Price vs. Fair Value
Below Fair Value: ORP (€114.85) is trading above our estimate of fair value (€39.57)
Significantly Below Fair Value: ORP is trading above our estimate of fair value.
Price To Earnings Ratio
PE vs Industry: ORP is poor value based on its PE Ratio (38.6x) compared to the FR Healthcare industry average (37x).
PE vs Market: ORP is poor value based on its PE Ratio (38.6x) compared to the French market (22.5x).
Price to Earnings Growth Ratio
PEG Ratio: ORP is poor value based on its PEG Ratio (1.9x)
Price to Book Ratio
PB vs Industry: ORP is overvalued based on its PB Ratio (2.5x) compared to the FR Healthcare industry average (2.4x).
How is Orpea forecast to perform in the next 1 to 3 years based on estimates from 11 analysts?
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: ORP's forecast earnings growth (20.2% per year) is above the savings rate (0.4%).
Earnings vs Market: ORP's earnings (20.2% per year) are forecast to grow slower than the French market (24.2% per year).
High Growth Earnings: earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: ORP's revenue (7.3% per year) is forecast to grow faster than the French market (7% per year).
High Growth Revenue: ORP's revenue (7.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: ORP's Return on Equity is forecast to be low in 3 years time (7.6%).
How has Orpea performed over the past 5 years?
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: ORP has a large one-off gain of €77.9M impacting its June 30 2020 financial results.
Growing Profit Margin: ORP's current net profit margins (5.1%) are lower than last year (6.4%).
Past Earnings Growth Analysis
Earnings Trend: ORP's earnings have grown by 8.9% per year over the past 5 years.
Accelerating Growth: ORP's has had negative earnings growth over the past year, so it can't be compared to its 5-year average.
Earnings vs Industry: ORP had negative earnings growth (-15.4%) over the past year, making it difficult to compare to the Healthcare industry average (-15.4%).
Return on Equity
High ROE: ORP's Return on Equity (6.3%) is considered low.
How is Orpea's financial position?
Financial Position Analysis
Short Term Liabilities: ORP's short term assets (€2.4B) do not cover its short term liabilities (€2.5B).
Long Term Liabilities: ORP's short term assets (€2.4B) do not cover its long term liabilities (€9.9B).
Debt to Equity History and Analysis
Debt Level: ORP's debt to equity ratio (235.2%) is considered high.
Reducing Debt: ORP's debt to equity ratio has increased from 176.3% to 235.2% over the past 5 years.
Debt Coverage: ORP's debt is not well covered by operating cash flow (12%).
Interest Coverage: ORP's interest payments on its debt are well covered by EBIT (3.3x coverage).
What is Orpea current dividend yield, its reliability and sustainability?
Forecast Dividend Yield
Dividend Yield vs Market
Notable Dividend: Unable to evaluate ORP's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
High Dividend: Unable to evaluate ORP's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
Stability and Growth of Payments
Stable Dividend: Insufficient data to determine if ORP's dividends per share have been stable in the past.
Growing Dividend: Insufficient data to determine if ORP's dividend payments have been increasing.
Current Payout to Shareholders
Dividend Coverage: ORP is not paying a notable dividend for the French market.
Future Payout to Shareholders
Future Dividend Coverage: No need to calculate the sustainability of ORP's dividend in 3 years as they are not forecast to pay a notable one for the French market.
How experienced are the management team and are they aligned to shareholders interests?
Average board tenure
Yves Le Masne (58 yo)
Mr. Yves Le Masne has been the Chief Executive Officer of Orpea SA since February 15, 2011 and served as its Chief Financial Officer and Chief Operating Officer since 2006. Previously, Mr. Le Masne served ...
CEO Compensation Analysis
Compensation vs Market: Yves's total compensation ($USD2.75M) is about average for companies of similar size in the French market ($USD2.94M).
Compensation vs Earnings: Yves's compensation has been consistent with company performance over the past year.
|CEO & Director||9.92yrs||€2.28m||0.031% |
|Independent Director||3.58yrs||€49.00k||0.00015% |
|Independent Non-Executive Chairman||3.83yrs||€300.00k||0.00062% |
|Independent Director||8.92yrs||€67.00k||no data|
|Honorary Chairman||3.83yrs||€577.32k||no data|
|Independent Director||9.58yrs||€58.00k||0.00024% |
|Independent Director||6.33yrs||€49.00k||0.000070% |
|Independent Director||4.08yrs||€38.00k||0.00031% |
|Independent Director||3.75yrs||€55.00k||0% |
|Independent Director||1.83yrs||€30.80k||0% |
|Director||1yr||no data||no data|
Experienced Board: ORP's board of directors are considered experienced (4 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Orpea SA's company bio, employee growth, exchange listings and data sources
- Name: Orpea SA
- Ticker: ORP
- Exchange: ENXTPA
- Founded: 1989
- Industry: Health Care Facilities
- Sector: Healthcare
- Market Cap: €7.110b
- Shares outstanding: 64.58m
- Website: https://www.orpea-corp.com
Number of Employees
- Orpea SA
- 12 rue Jean JaruEs
- CS 10032
|Ticker||Exchange||Primary Security||Security Type||Country||Currency||Listed on|
|ORP||ENXTPA (Euronext Paris)||Yes||Ordinary Shares||FR||EUR||Apr 2002|
|OPA||DB (Deutsche Boerse AG)||Yes||Ordinary Shares||DE||EUR||Apr 2002|
|0NEX||LSE (London Stock Exchange)||Yes||Ordinary Shares||GB||EUR||Apr 2002|
|ORPE.F||OTCPK (Pink Sheets LLC)||Yes||Ordinary Shares||US||USD||Apr 2002|
|ORPP||BATS-CHIXE (BATS 'Chi-X Europe')||Yes||Ordinary Shares||GB||EUR||Apr 2002|
|ORP N||BMV (Bolsa Mexicana de Valores)||Yes||Ordinary Shares||MX||MXN||Apr 2002|
|ORRR.Y||OTCPK (Pink Sheets LLC)||UNSPONSOR ADR||US||USD||Dec 2015|
ORPEA SA operates nursing homes, assisted-living facilities, post-acute and rehabilitation hospitals, and psychiatric hospitals. Its nursing home facilities provide personalized support services; and logis...
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2021/01/18 19:16|
|End of Day Share Price||2021/01/18 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.